Hedonic eating is controlled by dopamine neurons that oppose GLP-1R satiety.
Science · 2025
Last updated 2026-05-28A study in mice found that a brain pathway involving dopamine neurons drives eating for pleasure rather than hunger. The drug semaglutide, which is used to treat obesity, temporarily reduced this dopamine activity and food intake, but the mice eventually regained their appetite and brain response to palatable food over repeated use.
AI summary of the abstract below.
| Journal | Science, 2025 |
|---|---|
| Citations | 35 |
| Relative citation ratio | 13.64 |
| Molecules | — |
| Conditions studied | Obesity |
Abstract
Hedonic eating is defined as food consumption driven by palatability without physiological need. However, neural control of palatable food intake is poorly understood. We discovered that hedonic eating is controlled by a neural pathway from the peri-locus ceruleus to the ventral tegmental area (VTA). Using photometry-calibrated optogenetics, we found that VTA dopamine (VTA) neurons encode palatability to bidirectionally regulate hedonic food consumption. VTA neuron responsiveness was suppressed during food consumption by semaglutide, a glucagon-like peptide receptor 1 (GLP-1R) agonist used as an antiobesity drug. Mice recovered palatable food appetite and VTA neuron activity during repeated semaglutide treatment, which was reversed by consumption-triggered VTA neuron inhibition. Thus, hedonic food intake activates VTA neurons, which sustain further consumption, a mechanism that opposes appetite reduction by semaglutide.
Verbatim abstract via PubMed 40146831 ↗